Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non–Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study) Within 126 QPOP cases, 105 (52 B-NHL and 53 NK/T-NHL) ...
Guidelines advocate molecular profiling in the evaluation of advanced non–small-cell lung cancer (NSCLC) and support the use of plasma circulating tumor DNA (ctDNA)-based profiling for patients with ...
Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has demonstrated that it can predict the outcome of Phase II to Phase III ...
ATLANTA--(BUSINESS WIRE)--Cotiviti, a leader in data-driven healthcare solutions, is expanding its Clinical Chart Validation (CCV) solution and Prospective Accuracy claim review offerings with a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback